2023
1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study
HAIDER S, PARKER M, HUANG E, GRANT R, MOFFET H, LAITEERAPONG N, LIU J, LIPSKA K, KARTER A. 1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study. Diabetes 2023, 72 DOI: 10.2337/db23-1217-p.Peer-Reviewed Original ResearchType 2 diabetesOlder patientsKaiser Permanente Northern CaliforniaDe-intensify treatmentDuration of diabetesGlucose-lowering medicationsNumber of medicationsProportion of patientsClinical guideline recommendationsHealth status factorsPoor health statusCross-sectional analysisInsulin useComplex regimensLess medicationGuideline recommendationsPatients' willingnessAbbVie Inc.Side effectsDiabetesPatient experiencePatientsHealth statusHypoglycemia historyMedications
2021
882-P: QBSAFE: Pilot Study of an Intervention to Shift the Paradigm of Diabetes Care
CLARK J, BOEHMER K, BRESLIN M, HAIDER S, PASCIAK W, GRAVHOLT D, SANCHEZ B, HARTASANCHEZ S, EL KAWKGI O, MONTORI V, LIPSKA K. 882-P: QBSAFE: Pilot Study of an Intervention to Shift the Paradigm of Diabetes Care. Diabetes 2021, 70 DOI: 10.2337/db21-882-p.Peer-Reviewed Original ResearchDiabetes careSingle-arm pilot studyClinical encountersPilot studyMedication side effectsSubgroup of patientsBurden of treatmentFocus of careAddress patients' needsClinician-patient conversationsPost-visit surveysQuality of lifeRoutine clinical encountersHigh treatment costsUsual careGlycemic controlClinical visitsPatient participantsClinician participantsSide effectsPatientsPatient needsCliniciansTreatment costsQualitative semi-structured interviews